Core Viewpoint - A lawsuit has been filed against Acadia Healthcare Company, Inc. and certain senior executives, alleging misrepresentation of financial results related to insurance fraud and improper patient detainment practices [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until December 16, 2024, to request to lead the case [2]. Group 2: Allegations Against Acadia - Acadia is one of the largest for-profit psychiatric hospital chains in the U.S., accused of holding patients against their will and misrepresenting financial results [3]. - A New York Times investigation revealed that Acadia's success was partly due to these controversial practices, leading to a stock price drop of 78.21 on September 3, 2024 [4]. Group 3: Regulatory Scrutiny - On September 27, 2024, Acadia disclosed receiving requests for information from the U.S. Attorney's Office and a grand jury subpoena, resulting in a 16% decline in stock price from 63.28 [5]. - An October 18, 2024, article reported that the Veterans Affairs Department is investigating Acadia for potential insurance fraud, causing a further 12% decline in stock price from 52.03 [6].
ACHC CLASS ACTION ALERT: The Acadia Healthcare December 16 Securities Fraud Deadline is Approaching – Contact BFA Law if You Lost Money (NASDAQ:ACHC)